Offer for Investors:
- Invest in professionally vetted, unlisted Japanese startups; investment tiers are set individually per deal.
- Every deal includes a shareholder agreement between investor and company, meant to keep the company’s operations orderly as its shareholder base grows.
- Potential returns are pitched as “several to several hundred times” the investment on a successful IPO or acquisition — though most investee companies pay no dividends, and there’s no guarantee of an exit.
- Eligible deals can qualify for Japan’s angel-tax incentives.
- A separate, member-only product, Ecrowd NEXT, targets mid-to-later-stage pre-IPO companies for larger rounds; Academic Round focuses on university-spinout ventures.
Offer for Fundraisers:
- Ecrowd screens (“professionally vetted”) each company before listing.
- Standard national equity-crowdfunding limits apply on the main track: issuers typically raise up to ¥100 million a year, with individual retail investors capped at ¥500,000 per company per year.
- Companies that outgrow the standard track can move to Ecrowd NEXT for larger, member-only rounds.
- Exact fee structure for issuers isn’t published on the public site.
Individual investors register online via smartphone (email plus identity verification) and can invest the same day. Retail investors are capped at ¥500,000 per company per year under Japan’s national equity-crowdfunding rules;
Ecrowd also documents a specified/professional-investor track exempt from that cap. Losses can’t exceed the amount invested.
Ecrowd offers to invest in various crowdfunding opportunities from the Startups, Health & Science sector.
At Ecrowd, you can start investing with JP¥100,000.
The investment models Ecrowd operates is Equity.